Streptococcus intermedius/anginosus
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | + |
Imipenem | + |
|
| Azithromycin | -* |
Levofloxacin | 97 |
|
| Aztreonam | -* |
Meropenem | + |
|
| Cefazolin | 96 |
Moxifloxacin | +
|
|
| Cefepime | + |
Nitrofurantoin | &
|
|
| Ceftazidime | +/- |
Oxacillin/Naf | +-* |
|
| Ceftriaxone | 96 |
Penicillin | 88 |
|
| Cefuroxime | + |
Piperacillin | +
|
|
| Ciprofloxacin | +-* |
Piperacillin/tazo | + |
|
| Clarithromycin | +-* |
Ticarcillin/Clav | + |
|
| Clindamycin | 91 |
Tobramycin | -* |
|
| Doxycycline | 79 |
TMP/SMX | 72 |
|
| Erythromycin | 83 |
Unasyn/Aug | + |
|
| Gentamicin | -* |
Vancomycin | + |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
